IDO1 and neoplasm: In late tumor stages, sustained cGAMP expression by tumor cells leads to activation of downstream non-canonical NF-κB signaling pathways, releasing other pro-inflammatory cytokines such as IDO, thus creating an immunosuppressive tumor microenvironment that promotes tumor progression (69).